Curcumin Treatment Suppresses IKK Kinase Activity of Salivary Cells of Patients With Head and Neck Cancer: A Pilot Study

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-1272
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Factors Affecting Treatment Outcome in Elderly Head and Neck Cancer Patients: A Retrospective Pilot Study

Journal of Medical Imaging and Radiation Sciences
RadiologicalRadiologyNuclear MedicineUltrasound TechnologyImaging
2016English

Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients With Head and Neck Cancer

Clinical Cancer Research
Cancer ResearchOncology
2009English

The Symptom Burden of Treatment-Naive Patients With Head and Neck Cancer

Cancer
Cancer ResearchOncology
2014English

Curcumin: A Review of Anti-Cancer Properties and Therapeutic Activity in Head and Neck Squamous Cell Carcinoma

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2011English

Prereferral Head and Neck Cancer Treatment

Archives of Otolaryngology–Head & Neck Surgery
2010English

The Impact of Treatment on Quality of Life in Patients With Head and Neck Cancer

Iranian Journal of Public Health
EnvironmentalPublic HealthOccupational Health
2019English

Impact of Anemia in Patients With Head and Neck Cancer

Oncologist
Cancer ResearchMedicineOncology
2000English

Clinical Trial of Nintedanib in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck: A Multicenter Phase 2 Study (Korean Cancer Study Group HN14-01)

Cancer
Cancer ResearchOncology
2017English

Salivary Soluble CD44: A Potential Molecular Marker for Head and Neck Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy